FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's supplemental application for difluprednate ophthalmic, approving a generic corticosteroid ophthalmic solution for treating inflammator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis
• Inflammatory Diseases of the Eye
• Keratitis
• Postoperative Inflammation of the Eye

Drugs mentioned

• Difluprednate ophthalmic (Difluprednate)

Snippet

SUPPL AP for DIFLUPREDNATE OPHTHALMIC (DIFLUPREDNATE OPHTHALMIC)